{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T11:47:34Z","timestamp":1793879254657,"version":"4.7.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T00:00:00Z","timestamp":1677801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T00:00:00Z","timestamp":1677801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University","award":["No. ZYGD18017"],"award-info":[{"award-number":["No. ZYGD18017"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Polycystic ovarian syndrome (PCOS) is one of the most common causes of infertility in reproductive-age women. However, the efficacy and optimal therapeutic strategy for reproductive outcomes are still under debate. We conducted a systematic review and network meta-analysis to compare the efficacy of different first-line pharmacological therapies in terms of reproductive outcomes for women with PCOS and infertility.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A systematic retrieval of databases was conducted, and randomized clinical trials (RCTs) of pharmacological interventions for infertile PCOS women were included. The primary outcomes were clinical pregnancy and live birth, and the secondary outcomes were miscarriage, ectopic pregnancy and multiple pregnancy. A network meta-analysis based on a Bayesian model was performed to compare the effects of the pharmacological strategies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 27 RCTs with 12 interventions were included, and all therapies tended to increase clinical pregnancy, especially pioglitazone (PIO) (log OR 3.14, 95% CI 1.56\u2009~\u20094.70, moderate confidence), clomiphene citrate (CC)\u2009+\u2009exenatide (EXE) (2.96, 1.07\u2009~\u20094.82, moderate confidence) and CC\u2009+\u2009metformin (MET)\u2009+\u2009PIO (2.82, 0.99\u2009~\u20094.60, moderate confidence). Moreover, CC\u2009+\u2009MET\u2009+\u2009PIO (2.8, -0.25\u2009~\u20096.06, very low confidence) could increase live birth most when compared to placebo, even without a significant difference. For secondary outcomes, PIO showed a tendency to increase miscarriage (1.44, -1.69\u2009~\u20095.28, very low confidence). MET (-11.25, -33.7\u2009~\u20090.57, low confidence) and LZ\u2009+\u2009MET (-10.44, -59.56\u2009~\u200942.11, very low confidence) were beneficial for decreasing ectopic pregnancy. MET (0.07, -4.26\u2009~\u20094.34, low confidence) showed a neutral effect in multiple pregnancy. Subgroup analysis demonstrated no significant difference between these medications and placebo in obese participants.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Most first-line pharmacological treatments were effective in improving clinical pregnancy. CC\u2009+\u2009MET\u2009+\u2009PIO should be recommended as the optimal therapeutic strategy to improve pregnancy outcomes. However, none of the above treatments had a beneficial effect on clinical pregnancy in obese PCOS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration<\/jats:title><jats:p>CRD42020183541; 05 July 2020<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12958-023-01075-9","type":"journal-article","created":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T10:03:54Z","timestamp":1677837834000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["The effects of first-line pharmacological treatments for reproductive outcomes in infertile women with PCOS: a systematic review and network meta-analysis"],"prefix":"10.1186","volume":"21","author":[{"given":"Ge","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanwei","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,3]]},"reference":[{"issue":"1","key":"1075_CR1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","volume":"97","author":"BC Fauser","year":"2012","unstructured":"Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, et al. Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. 2012;97(1):28-38 e25.","journal-title":"Fertil Steril"},{"issue":"5","key":"1075_CR2","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrendo.2018.24","volume":"14","author":"HF Escobar-Morreale","year":"2018","unstructured":"Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14(5):270\u201384.","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"1075_CR3","doi-asserted-by":"publisher","first-page":"e157","DOI":"10.1097\/AOG.0000000000002656","volume":"131","author":"Obstetricians ACo","year":"2018","unstructured":"Obstetricians ACo, Bulletins-Gynecology GCoP. ACOG Practice Bulletin No. 194: Polycystic Ovary Syndrome. Obstet Gynecol. 2018;131(6):e157\u201371.","journal-title":"Obstet Gynecol"},{"issue":"9","key":"1075_CR4","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1093\/humrep\/dey256","volume":"33","author":"HJ Teede","year":"2018","unstructured":"Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod (Oxford, England). 2018;33(9):1602\u201318.","journal-title":"Hum Reprod (Oxford, England)"},{"issue":"21","key":"1075_CR5","doi-asserted-by":"publisher","first-page":"8147","DOI":"10.3390\/ijms21218147","volume":"21","author":"KM Seow","year":"2020","unstructured":"Seow KM, Chang YW, Chen KH, Juan CC, Huang CY, Lin LT, et al. Molecular Mechanisms of Laparoscopic Ovarian Drilling and Its Therapeutic Effects in Polycystic Ovary Syndrome. Int J Mol Sci. 2020;21(21):8147.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1075_CR6","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s12020-019-01860-w","volume":"64","author":"AR Wang","year":"2019","unstructured":"Wang AR, Mo TT, Li Q, Shen CP, Liu M. The effectiveness of metformin, oral contraceptives, and lifestyle modification in improving the metabolism of overweight women with polycystic ovary syndrome: a network meta-analysis. Endocrine. 2019;64(2):220\u201332.","journal-title":"Endocrine"},{"key":"1075_CR7","volume-title":"Fertility: Assessment and Treatment for People with Fertility Problems","author":"National Collaborating Centre for Ws, Children\u2019s H. National Institute for Health and Clinical Excellence: Guidance","year":"2013","unstructured":"National Collaborating Centre for Ws, Children\u2019s H. National Institute for Health and Clinical Excellence: Guidance. Fertility: Assessment and Treatment for People with Fertility Problems. London: Royal College of Obstetricians & Gynaecologists; 2013. Copyright \u00a9 2013, National Collaborating Centre for Women\u2019s and Children\u2019s Health."},{"issue":"6","key":"1075_CR8","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1093\/humupd\/dmz029","volume":"25","author":"R Wang","year":"2019","unstructured":"Wang R, Li W, Bordewijk EM, Legro RS, Zhang H, Wu X, et al. First-line ovulation induction for polycystic ovary syndrome: an individual participant data meta-analysis. Hum Reprod Update. 2019;25(6):717\u201332.","journal-title":"Hum Reprod Update"},{"issue":"7","key":"1075_CR9","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.","journal-title":"PLoS Med"},{"key":"1075_CR10","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ (Clin Res Ed). 2011;343:d5928.","journal-title":"BMJ (Clin Res Ed)"},{"issue":"4","key":"1075_CR11","doi-asserted-by":"publisher","first-page":"e1003082","DOI":"10.1371\/journal.pmed.1003082","volume":"17","author":"A Nikolakopoulou","year":"2020","unstructured":"Nikolakopoulou A, Higgins JPT, Papakonstantinou T, Chaimani A, Del Giovane C, Egger M, et al. CINeMA: an approach for assessing confidence in the results of a network meta-analysis. PLoS Med. 2020;17(4):e1003082.","journal-title":"PLoS Med"},{"issue":"7109","key":"1075_CR12","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clin Res Ed). 1997;315(7109):629\u201334.","journal-title":"BMJ (Clin Res Ed)"},{"key":"1075_CR13","unstructured":"Kuiper GvVaJ. gemtc: Network Meta-Analysis Using Bayesian Methods 2020. Available from: https:\/\/CRAN.R-project.org\/package=gemtc."},{"key":"1075_CR14","unstructured":"Team RC. R: A language and environment for statistical computing. Vienna, Austria.\u00a02019. Available from: https:\/\/www.R-project.org\/."},{"issue":"5","key":"1075_CR15","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1177\/0272989X12458724","volume":"33","author":"S Dias","year":"2013","unstructured":"Dias S, Sutton AJ, Ades AE, Welton NJ. Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials. Med Decis Making. 2013;33(5):607\u201317.","journal-title":"Med Decis Making"},{"key":"1075_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jclinepi.2019.03.007","volume":"111","author":"AA Veroniki","year":"2019","unstructured":"Veroniki AA, Bender R, Glasziou P, Straus SE, Tricco AC. The number needed to treat in pairwise and network meta-analysis and its graphical representation. J Clin Epidemiol. 2019;111:11\u201322.","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"1075_CR17","first-page":"434","volume":"7","author":"P Stephen","year":"1996","unstructured":"Stephen P, Brooks AG. General Methods for Monitoring Convergence of Iterative Simulations. J Comput Graph Stat. 1996;7(4):434\u201355.","journal-title":"J Comput Graph Stat"},{"issue":"7414","key":"1075_CR18","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ (Clin Res Ed). 2003;327(7414):557\u201360.","journal-title":"BMJ (Clin Res Ed)"},{"issue":"4","key":"1075_CR19","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.soard.2011.05.013","volume":"7","author":"JB Dixon","year":"2011","unstructured":"Dixon JB, Zimmet P, Alberti KG, Rubino F. Bariatric surgery: an IDF statement for obese Type 2 diabetes. Surg Obes Relat Dis. 2011;7(4):433\u201347.","journal-title":"Surg Obes Relat Dis"},{"issue":"1","key":"1075_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa1614362","volume":"377","author":"A Afshin","year":"2017","unstructured":"Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, Lee A, et al. Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med. 2017;377(1):13\u201327.","journal-title":"N Engl J Med"},{"issue":"8","key":"1075_CR21","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1093\/humrep\/dex227","volume":"32","author":"SA Amer","year":"2017","unstructured":"Amer SA, Smith J, Mahran A, Fox P, Fakis A. Double-blind randomized controlled trial of letrozole versus clomiphene citrate in subfertile women with polycystic ovarian syndrome. Hum Reprod (Oxford, England). 2017;32(8):1631\u20138.","journal-title":"Hum Reprod (Oxford, England)"},{"issue":"2","key":"1075_CR22","first-page":"199","volume":"6","author":"A Ayaz","year":"2013","unstructured":"Ayaz A, Alwan Y, Farooq MU. Efficacy of combined metformin-clomiphene citrate in comparison with clomiphene citrate alone in infertile women with polycystic ovarian syndrome (PCOS). J Med Life. 2013;6(2):199\u2013201.","journal-title":"J Med Life"},{"issue":"3","key":"1075_CR23","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/ijgo.13375","volume":"152","author":"S Bansal","year":"2021","unstructured":"Bansal S, Goyal M, Sharma C, Shekhar S. Letrozole versus clomiphene citrate for ovulation induction in anovulatory women with polycystic ovarian syndrome: a randomized controlled trial. Int J Gynaecol Obstet. 2021;152(3):345\u201350.","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"1075_CR24","first-page":"285","volume":"43","author":"A Fatima","year":"2018","unstructured":"Fatima A, Khan SA, Saifuddin Z, Aslam R. Comparison of efficacy of clomiphene citrate alone and with metformin for treatment of infertility in polycystic ovarian syndrome. Rawal Med J. 2018;43(2):285\u20138.","journal-title":"Rawal Med J"},{"issue":"1","key":"1075_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.mefs.2013.05.003","volume":"19","author":"GA Fattah","year":"2014","unstructured":"Fattah GA, Al Mohammady M, Hamed DA. Combined pioglitazone-metformin and clomiphene citrate versus metformin and clomiphene citrate in induction of ovulation in women with clomiphene citrate-resistant polycystic ovary syndrome. Middle East Fertil Soc J. 2014;19(1):27\u201333.","journal-title":"Middle East Fertil Soc J"},{"key":"1075_CR26","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4103\/2277-9175.175237","volume":"5","author":"A Ghahiri","year":"2016","unstructured":"Ghahiri A, Mogharehabed N, Mamourian M. Letrozole as the first-line treatment of infertile women with poly cystic ovarian syndrome (PCOS) compared with clomiphene citrate: a clinical trial. Adv Biomed Res. 2016;5:6.","journal-title":"Adv Biomed Res"},{"issue":"7","key":"1075_CR27","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1093\/humrep\/deq100","volume":"25","author":"NP Johnson","year":"2010","unstructured":"Johnson NP, Stewart AW, Falkiner J, Farquhar CM, Milsom S, Singh VP, et al. PCOSMIC: a multi-centre randomized trial in women with PolyCystic Ovary Syndrome evaluating Metformin for Infertility with Clomiphene. Hum Reprod (Oxford, England). 2010;25(7):1675\u201383.","journal-title":"Hum Reprod (Oxford, England)"},{"issue":"4","key":"1075_CR28","doi-asserted-by":"publisher","first-page":"197","DOI":"10.4103\/0974-1208.170373","volume":"8","author":"S Kar","year":"2015","unstructured":"Kar S, Sanchita S. Clomiphene citrate, metformin or a combination of both as the first line ovulation induction drug for Asian Indian women with polycystic ovarian syndrome: a randomized controlled trial. J Hum Reprod Sci. 2015;8(4):197\u2013201.","journal-title":"J Hum Reprod Sci"},{"issue":"3","key":"1075_CR29","first-page":"174","volume":"12","author":"MA Karimzadeh","year":"2007","unstructured":"Karimzadeh MA, Eftekhar M, Taheripanah R, Tayebi N, Sakhavat L, Zare F. The effect of administration of metformin on lipid profile changes and insulin resistance in patients with polycystic ovary syndrome. Middle East Fertil Soc J. 2007;12(3):174\u20138.","journal-title":"Middle East Fertil Soc J"},{"issue":"1","key":"1075_CR30","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.fertnstert.2009.02.078","volume":"94","author":"MA Karimzadeh","year":"2010","unstructured":"Karimzadeh MA, Javedani M. An assessment of lifestyle modification versus medical treatment with clomiphene citrate, metformin, and clomiphene citrate-metformin in patients with polycystic ovary syndrome. Fertil Steril. 2010;94(1):216\u201320.","journal-title":"Fertil Steril"},{"issue":"6","key":"1075_CR31","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1056\/NEJMoa063971","volume":"356","author":"RS Legro","year":"2007","unstructured":"Legro RS, Barnhart HX, Schlaff WD, Carr BR, Diamond MP, Carson SA, et al. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med. 2007;356(6):551\u201366.","journal-title":"N Engl J Med"},{"issue":"2","key":"1075_CR32","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1056\/NEJMoa1313517","volume":"371","author":"RS Legro","year":"2014","unstructured":"Legro RS, Brzyski RG, Diamond MP, Coutifaris C, Schlaff WD, Casson P, et al. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med. 2014;371(2):119\u201329.","journal-title":"N Engl J Med"},{"issue":"11","key":"1075_CR33","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1080\/09513590.2017.1332174","volume":"33","author":"C Liu","year":"2017","unstructured":"Liu C, Feng G, Huang W, Wang Q, Yang S, Tan J, et al. Comparison of clomiphene citrate and letrozole for ovulation induction in women with polycystic ovary syndrome: a prospective randomized trial. Gynecol Endocrinol. 2017;33(11):872\u20136.","journal-title":"Gynecol Endocrinol"},{"issue":"6","key":"1075_CR34","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1111\/cen.13454","volume":"87","author":"X Liu","year":"2017","unstructured":"Liu X, Zhang Y, Zheng SY, Lin R, Xie YJ, Chen H, et al. Efficacy of exenatide on weight loss, metabolic parameters and pregnancy in overweight\/obese polycystic ovary syndrome. Clin Endocrinol. 2017;87(6):767\u201374.","journal-title":"Clin Endocrinol"},{"issue":"4","key":"1075_CR35","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3109\/09513590.2011.614207","volume":"28","author":"IA Mohsen","year":"2012","unstructured":"Mohsen IA. A randomized controlled trial of the effect of rosiglitazone and clomiphene citrate versus clomiphene citrate alone in overweight\/obese women with polycystic ovary syndrome. Gynecol Endocrinol. 2012;28(4):269\u201372.","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"1075_CR36","first-page":"350","volume":"13","author":"R Mohsin","year":"2019","unstructured":"Mohsin R, Saeed A, Baig MM, Khan M. Role of letrozole and metformin vs letrozole alone in ovulation induction in patients of polycystic ovarian syndrome. Pak J Med Health Sci. 2019;13(1):350\u20132.","journal-title":"Pak J Med Health Sci"},{"issue":"8","key":"1075_CR37","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1093\/humrep\/den182","volume":"23","author":"E Moll","year":"2008","unstructured":"Moll E, Korevaar JC, Bossuyt PM, van der Veen F. Does adding metformin to clomifene citrate lead to higher pregnancy rates in a subset of women with polycystic ovary syndrome? Hum Reprod (Oxford, England). 2008;23(8):1830\u20134.","journal-title":"Hum Reprod (Oxford, England)"},{"issue":"2","key":"1075_CR38","doi-asserted-by":"publisher","first-page":"88","DOI":"10.5530\/ami.2016.2.19","volume":"3","author":"AA Moussa","year":"2016","unstructured":"Moussa AA, Torky H, Dief O, Elwahed AA, Senna HA. The effect of clomiphene citrate versus tamoxifen versus letrozol on endometrial thickness and blood flow in ovulation induction in women with polycystic ovaries. Acta Med Int. 2016;3(2):88\u201392.","journal-title":"Acta Med Int"},{"issue":"3","key":"1075_CR39","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1210\/jc.2004-1965","volume":"90","author":"C Ortega-Gonz\u00e1lez","year":"2005","unstructured":"Ortega-Gonz\u00e1lez C, Luna S, Hern\u00e1ndez L, Crespo G, Aguayo P, Arteaga-Troncoso G, et al. Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese, insulin-resistant women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005;90(3):1360\u20135.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1075_CR40","doi-asserted-by":"publisher","first-page":"4068","DOI":"10.1210\/jc.2005-0110","volume":"90","author":"S Palomba","year":"2005","unstructured":"Palomba S, Orio F Jr, Falbo A, Manguso F, Russo T, Cascella T, et al. Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005;90(7):4068\u201374.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1075_CR41","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.fertnstert.2005.07.1312","volume":"85","author":"AA Rouzi","year":"2006","unstructured":"Rouzi AA, Ardawi MS. A randomized controlled trial of the efficacy of rosiglitazone and clomiphene citrate versus metformin and clomiphene citrate in women with clomiphene citrate-resistant polycystic ovary syndrome. Fertil Steril. 2006;85(2):428\u201335.","journal-title":"Fertil Steril"},{"issue":"2","key":"1075_CR42","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.mefs.2010.11.004","volume":"16","author":"M Sheikh-El-Arab Elsedeek","year":"2011","unstructured":"Sheikh-El-Arab Elsedeek M, Elmaghraby HAH. Predictors and characteristics of letrozole induced ovulation in comparison with clomiphene induced ovulation in anovulatory PCOS women. Middle East Fertil Soc J. 2011;16(2):125\u201330.","journal-title":"Middle East Fertil Soc J"},{"issue":"3","key":"1075_CR43","first-page":"1240","volume":"12","author":"SZ Syed","year":"2018","unstructured":"Syed SZ, Akram F, Aftab Hassan SM. Comparison of efficacy of metformin versus Pioglitazone on ovulation in patients of polycystic ovarian syndrome. Pak J Med Health Sci. 2018;12(3):1240\u20132.","journal-title":"Pak J Med Health Sci"},{"issue":"2","key":"1075_CR44","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/S0015-0282(00)01675-7","volume":"75","author":"DT Vandermolen","year":"2001","unstructured":"Vandermolen DT, Ratts VS, Evans WS, Stovall DW, Kauma SW, Nestler JE. Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone. Fertil Steril. 2001;75(2):310\u20135.","journal-title":"Fertil Steril"},{"issue":"19","key":"1075_CR45","first-page":"8406","volume":"28","author":"J Wang","year":"2017","unstructured":"Wang J, Ruan X, Jin F, Sun Y, Wang J. Effects of exenatide combined with clomifene citrate on insulin resistance and angiotensin II\/Angiotensin-(1\u20137) in peripheral blood in patients with polycystic ovary syndrome. Biomed Res (India). 2017;28(19):8406\u201311.","journal-title":"Biomed Res (India)"},{"key":"1075_CR46","doi-asserted-by":"publisher","first-page":"532692","DOI":"10.3389\/fendo.2020.532692","volume":"11","author":"L Wang","year":"2021","unstructured":"Wang L, Lv S, Li F, Bai E, Yang X. Letrozole Versus Clomiphene Citrate and Natural Cycle: Endometrial Receptivity During Implantation Window in Women With Polycystic Ovary Syndrome. Front Endocrinol. 2021;11:532692.","journal-title":"Front Endocrinol"},{"issue":"2","key":"1075_CR47","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.fertnstert.2007.12.002","volume":"91","author":"MM Zain","year":"2009","unstructured":"Zain MM, Jamaluddin R, Ibrahim A, Norman RJ. Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction, achievement of pregnancy, and live birth in Asian women with polycystic ovary syndrome: a randomized controlled trial. Fertil Steril. 2009;91(2):514\u201321.","journal-title":"Fertil Steril"},{"issue":"4","key":"1075_CR48","first-page":"450","volume":"68","author":"W Vitek","year":"2016","unstructured":"Vitek W, Hoeger K, Legro RS. Treatment strategies for infertile women with polycystic ovary syndrome. Minerva Ginecol. 2016;68(4):450\u20137.","journal-title":"Minerva Ginecol"},{"issue":"4","key":"1075_CR49","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s00404-017-4480-z","volume":"296","author":"Y Xu","year":"2017","unstructured":"Xu Y, Wu Y, Huang Q. Comparison of the effect between pioglitazone and metformin in treating patients with PCOS:a meta-analysis. Arch Gynecol Obstet. 2017;296(4):661\u201377.","journal-title":"Arch Gynecol Obstet"},{"key":"1075_CR50","doi-asserted-by":"publisher","first-page":"657889","DOI":"10.3389\/fendo.2021.657889","volume":"12","author":"Y Liu","year":"2021","unstructured":"Liu Y, Li J, Yan Z, Liu D, Ma J, Tong N. Improvement of Insulin Sensitivity Increases Pregnancy Rate in Infertile PCOS Women: A Systemic Review. Front Endocrinol. 2021;12:657889.","journal-title":"Front Endocrinol"},{"key":"1075_CR51","doi-asserted-by":"crossref","first-page":"263349412090870","DOI":"10.1177\/2633494120908709","volume":"14","author":"D Romualdi","year":"2020","unstructured":"Romualdi D, Versace V, Lanzone A. What is new in the landscape of insulin-sensitizing agents for polycystic ovary syndrome treatment. Ther Adv Reprod Health. 2020;14:2633494120908709.","journal-title":"Ther Adv Reprod Health"},{"issue":"8","key":"1075_CR52","doi-asserted-by":"publisher","first-page":"e2695","DOI":"10.1210\/clinem\/dgaa285","volume":"105","author":"H Cena","year":"2020","unstructured":"Cena H, Chiovato L, Nappi RE. Obesity, Polycystic Ovary Syndrome, and Infertility: A New Avenue for GLP-1 Receptor Agonists. J Clin Endocrinol Metab. 2020;105(8):e2695\u2013709.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1075_CR53","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1093\/humupd\/dmz019","volume":"25","author":"M Jensterle","year":"2019","unstructured":"Jensterle M, Janez A, Fliers E, DeVries JH, Vrtacnik-Bokal E, Siegelaar SE. The role of glucagon-like peptide-1 in reproduction: from physiology to therapeutic perspective. Hum Reprod Update. 2019;25(4):504\u201317.","journal-title":"Hum Reprod Update"},{"issue":"2","key":"1075_CR54","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.rbmo.2019.04.017","volume":"39","author":"Y Han","year":"2019","unstructured":"Han Y, Li Y, He B. GLP-1 receptor agonists versus metformin in PCOS: a systematic review and meta-analysis. Reprod Biomed Online. 2019;39(2):332\u201342.","journal-title":"Reprod Biomed Online"},{"issue":"7","key":"1075_CR55","first-page":"2361","volume":"83","author":"B Imani","year":"1998","unstructured":"Imani B, Eijkemans MJ, te Velde ER, Habbema JD, Fauser BC. Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab. 1998;83(7):2361\u20135.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1075_CR56","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/humrep\/des463","volume":"28","author":"NK Stepto","year":"2013","unstructured":"Stepto NK, Cassar S, Joham AE, Hutchison SK, Harrison CL, Goldstein RF, et al. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp. Hum Reprod (Oxford, England). 2013;28(3):777\u201384.","journal-title":"Hum Reprod (Oxford, England)"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-023-01075-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12958-023-01075-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-023-01075-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T06:24:51Z","timestamp":1702016691000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-023-01075-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,3]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1075"],"URL":"https:\/\/doi.org\/10.1186\/s12958-023-01075-9","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,3]]},"assertion":[{"value":"15 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24"}}